Cyclerion Therapeutics Inc (CYCN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Sales | 711 | 532 | 348 | 3,000 | 62 |
| Gross Profit | 711 | 532 | 348 | 3,000 | 62 |
| Operating Expenses | 13,695 | 14,871 | 11,633 | 19,176 | 13,457 |
| Operating Income | -12,984 | -14,339 | -11,285 | -16,176 | -13,395 |
| Other Income | 6 | 3,563 | -5 | -6 | -4 |
| Pre-tax Income | -12,978 | -10,776 | -11,290 | -16,182 | -13,399 |
| Net Income Continuous | -12,978 | -10,776 | -11,290 | -16,182 | -13,399 |
| Net Income | $-12,978 | $-10,776 | $-11,290 | $-16,182 | $-13,399 |
| EPS Basic Total Ops | -6.00 | -4.40 | -5.20 | -9.00 | -7.80 |
| EPS Basic Continuous Ops | -5.98 | -4.25 | -5.22 | -9.06 | -7.86 |
| EPS Diluted Total Ops | -6.00 | -4.40 | -5.20 | -9.00 | -7.80 |
| EPS Diluted Continuous Ops | -5.98 | -4.25 | -5.22 | -9.06 | -7.86 |
| EBITDA(a) | $-12,936 | $-14,291 | $-11,237 | $-16,058 | $-13,137 |